Prelude Capital Management, LLC Curis Inc Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $80,370 - $175,520	-10,788 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $94,718 - $138,086	10,788 New	10,788 $122,000
Q4 2018 Feb 14, 2019	SELL	$0.62 - $2.25 $243 - $882	-392 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.38 - $1.94 $22 - $31	16 Added 4.26%	392 $1,000
Q2 2018 Aug 14, 2018	BUY	$1.73 - $3.35 $650 - $1,259	376 New	376 $1,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.